Literature DB >> 1325586

Neuroendocrine responses to cocaine do not exhibit sensitization following repeated cocaine exposure.

A D Levy1, Q Li, M C Alvarez Sanz, P A Rittenhouse, J E Kerr, L D Van de Kar.   

Abstract

Cocaine-induced enhancement of motor activity and extracellular dopamine concentrations exhibits sensitization upon repeated exposure. In this study, the neuroendocrine responses to cocaine were examined following cocaine pretreatment regimens which have been shown to produce behavioral sensitization. Adult male rats were injected with cocaine (15 mg/kg, IP) once daily for 14 days, followed by a dose-response challenge with cocaine (1-15 mg/kg, IP) either 18 hours or 7 days after the final pretreatment injection. Blood was collected 15 minutes following injections for radioimmunoassay of ACTH, corticosterone, prolactin, and renin. Cocaine increased plasma ACTH and corticosterone, while it decreased prolactin and renin concentrations. Pretreatment with cocaine for 2 weeks did not alter any of these endocrine responses after either the 18 hour or 7 day interval between pretreatment and challenge injections. In contrast, sensitization to the locomotor stimulant effects of cocaine was observed on the final day of pretreatment injections, and 7 days later. These data suggest that these endocrine effects of cocaine do not exhibit sensitization following repeated cocaine exposure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325586     DOI: 10.1016/0024-3205(92)90396-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Persistent increase in hypothalamic arginine vasopressin gene expression during protracted withdrawal from chronic escalating-dose cocaine in rodents.

Authors:  Yan Zhou; Yoav Litvin; Anna Paola Piras; Donald W Pfaff; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2011-06-15       Impact factor: 7.853

2.  Effects of chronic cocaine on monoamine levels in discrete brain structures of lactating rat dams.

Authors:  D A Lubin; J B Cannon; M C Black; L E Brown; J M Johns
Journal:  Pharmacol Biochem Behav       Date:  2003-01       Impact factor: 3.533

3.  Restraint-induced corticosterone secretion and hypothalamic CRH mRNA expression are augmented during acute withdrawal from chronic cocaine administration.

Authors:  John R Mantsch; Sarah Taves; Tayyiba Khan; Eric S Katz; Tanveer Sajan; Lee C Tang; William E Cullinan; Dana R Ziegler
Journal:  Neurosci Lett       Date:  2007-01-21       Impact factor: 3.046

4.  Involvement of tissue plasminogen activator in stress responsivity during acute cocaine withdrawal in mice.

Authors:  Yan Zhou; Rajani Maiya; Erin H Norris; Mary Jeanne Kreek; Sidney Strickland
Journal:  Stress       Date:  2010-07-28       Impact factor: 3.493

5.  Gestational treatment with cocaine and fluoxetine alters oxytocin receptor number and binding affinity in lactating rat dams.

Authors:  Josephine M Johns; Deborah A Lubin; Cheryl H Walker; Paul Joyner; Christopher Middleton; Vivian Hofler; Matthew McMurray
Journal:  Int J Dev Neurosci       Date:  2004 Aug-Oct       Impact factor: 2.457

6.  Daily cocaine self-administration under long-access conditions augments restraint-induced increases in plasma corticosterone and impairs glucocorticoid receptor-mediated negative feedback in rats.

Authors:  John R Mantsch; William E Cullinan; Lee C Tang; David A Baker; Eric S Katz; Michael A Hoks; Dana R Ziegler
Journal:  Brain Res       Date:  2007-07-14       Impact factor: 3.252

7.  Repeated amphetamine administration in rats revealed consistency across days and a complete dissociation between locomotor and hypothalamic-pituitary-adrenal axis effects of the drug.

Authors:  Humberto Gagliano; Raül Andero; Antonio Armario; Roser Nadal
Journal:  Psychopharmacology (Berl)       Date:  2009-10-07       Impact factor: 4.530

8.  Effect of the glucocorticoid receptor antagonist RU486 on MK-801 induced behavioural sensitisation.

Authors:  Emilia M Lefevre; Gregory A Medley; Timothy Reeks; Suzy Alexander; Thomas H J Burne; Darryl W Eyles
Journal:  PLoS One       Date:  2017-04-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.